Loading…
Based on limited metadata, this Warning Letter issued to JCM Dropship on September 6, 2019, concerns drug products. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the metadata provided. The letter falls under FDA's drug product regulatory authority, though the specific issuing office is not identified in the available information. Additional details about the particular violations would require review of the complete Warning Letter document.